Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series

Table 5

Actual survival times and expected survival probabilities.

Patient	Actual survival (months)	Expected 6-month survival probability	Expected 12-month survival probability	Expected 24-month survival probability
1	11.2	0.75	0.33	0.10
2	33.0 (ongoing)	0.94	0.81	0.54
3	5.2	0.80	0.42	0.10
4	18.0	0.92	0.75	0.44
5	18.6	0.91	0.71	0.36
6	9.5	0.93	0.77	0.46
7	14.8	0.87	0.60	0.23
8	9.4	0.68	0.23	0.10
9	21.6	0.86	0.56	0.19
10	8.7	0.89	0.65	0.28

Expected survival probabilities were calculated using the NRG oncology/RTOG 0525 and 0825 survival calculator at http://cancer4.case.edu/rCalculator/rCalculator.html.